Insider · CIK 0001768867
Katherine Beebe
Files at TTNP (TITAN PHARMACEUTICALS INC). First filing -, latest -.
In brief
Katherine Beebe files SEC Form 4 as COO, president and director at TTNP (TITAN PHARMACEUTICALS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Katherine Beebe has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 25, 2023 | TTNP TITAN PHARMACEUTICALS INC | AGrant or award Common Stock | +16,250 | $0.00 | $0 | 66,250 | Oct 26, 2023 |
Questions about Katherine Beebe
Answered from the filings on this page, as of the latest one.
Is Katherine Beebe buying or selling?
Katherine Beebe has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Katherine Beebe's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Katherine Beebe has 0.
Where does Katherine Beebe file Form 4?
Katherine Beebe has filed Form 4 at TTNP (TITAN PHARMACEUTICALS INC) as President and COO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.